Your browser doesn't support javascript.
loading
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
Moore, K N; Oza, A M; Colombo, N; Oaknin, A; Scambia, G; Lorusso, D; Konecny, G E; Banerjee, S; Murphy, C G; Tanyi, J L; Hirte, H; Konner, J A; Lim, P C; Prasad-Hayes, M; Monk, B J; Pautier, P; Wang, J; Berkenblit, A; Vergote, I; Birrer, M J.
Afiliação
  • Moore KN; Department of Obstetrics and Gynecology, Stephenson Cancer Center/University of Oklahoma Health Sciences Center, Oklahoma City, USA. Electronic address: kathleen-moore@ouhsc.edu.
  • Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Colombo N; Department of Gynecologic Oncology, European Institute of Oncology IRCCS; University of Milan-Bicocca, Milan, Italy.
  • Oaknin A; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Scambia G; Gynecology Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy.
  • Lorusso D; Gynecologic Oncology, Fondazione IRCCS National Cancer Institute, Milan, Italy.
  • Konecny GE; Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, USA.
  • Banerjee S; Gynaecology, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.
  • Murphy CG; Cancer Trials Ireland and Medical Oncology, Bon Secours Hospital, Cork, Ireland.
  • Tanyi JL; Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, USA.
  • Hirte H; Oncology, Juravinski Cancer Centre, Hamilton, Canada.
  • Konner JA; Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Lim PC; Gynecologic Oncology, The Center of Hope Renown Regional Medical Center, Reno, USA.
  • Prasad-Hayes M; Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Monk BJ; Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona, Creighton University School of Medicine, Phoenix, USA.
  • Pautier P; Medicine, Gustave Roussy, Villejuif, GINECO, Villejuif, France.
  • Wang J; Clinical Development, ImmunoGen, Inc., Waltham, USA.
  • Berkenblit A; Clinical Development, ImmunoGen, Inc., Waltham, USA.
  • Vergote I; Department of Obstetrics and Gynecology and Gynecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Birrer MJ; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA.
Ann Oncol ; 32(6): 757-765, 2021 06.
Article em En | MEDLINE | ID: mdl-33667670
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Imunoconjugados / Maitansina Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Imunoconjugados / Maitansina Idioma: En Ano de publicação: 2021 Tipo de documento: Article